Immunization

The Pharmacy Times® Immunization resource center provides the latest news in immunization. Here, you’ll find information about upcoming conferences and meetings, updated clinical trial listings, and other resources for those interested in vaccination.

What can we help you find?
[[thumbnail_alt_text]]
Pfizer and BioNTech, and Moderna have announced agreements to further supply vaccines against the coronavirus disease 2019 (COVID-19).
[[thumbnail_alt_text]]
Earlier this month, the Canadian government also exercised its option to increase its confirmed order commitment of mRNA-1273.
[[thumbnail_alt_text]]
This agreement brings the total number to be delivered to the United States to 200 million.
[[thumbnail_alt_text]]
Pharmacy Times® interviewed Michael Flannery, PharmD, the assistant director of pharmacy operations at the University of Rochester Medical Center, on the process for managing the waiting period in the pharmacy following COVID-19 immunizations.
[[thumbnail_alt_text]]
Pharmacy Times® interviewed Michael Flannery, PharmD, the assistant director of pharmacy operations at the University of Rochester Medical Center, on the process for immunizing staff at a hospital pharmacy with the COVID-19 vaccines.
[[thumbnail_alt_text]]
Pharmacy Times® interviewed Michael Flannery, PharmD, of the University of Rochester Medical Center, on the process that the hospital pharmacy has developed for vaccinations following the arrival of the Pfizer and Moderna COVID-19 vaccines.
[[thumbnail_alt_text]]
Pharmacy Times® interviewed Michael Flannery, PharmD, the assistant director of pharmacy operations at the University of Rochester Medical Center, on the concerns he has regarding the COVID-19 vaccination process ahead.
[[thumbnail_alt_text]]
The action allows for medicinal products to be authorized on a conditional basis for seriously debilitating or life-threatening diseases or for use in emergency situations in response to public health threats in the European Union.
[[thumbnail_alt_text]]
The ACIP advises the CDC on the populations and circumstances for which vaccines should be used.
[[thumbnail_alt_text]]
Moderna’s COVID-19 vaccine (mRNA-1273) has been granted Emergency Use Authorization (EUA) by the FDA, making it the second vaccine to be issued an EUA for combating the virus.
[[thumbnail_alt_text]]
Pharmacy Times® interviewed Sue Peschin, president and CEO of Alliance for Aging Research, on the work that the COVID-19 Vaccine Education and Equity Project is doing to engage diverse constituencies on the importance of the clinical trials process, regulatory review, and equitable access to COVID-19 vaccines.